Cargando…
Tranilast enhances the effect of anticancer agents in osteosarcoma
Tranilast [N-(3′,4′-dimethoxycinnamoyl)-anthranilic acid], initially developed as an antiallergic drug, also exhibits a growth inhibitory effect on various types of cancer. Osteosarcoma is treated mainly with high-dose methotrexate, doxorubicin, cisplatin and ifosfamide; however, 20–30 % of patients...
Autores principales: | Nakashima, Takayuki, Nagano, Satoshi, Setoguchi, Takao, Sasaki, Hiromi, Saitoh, Yoshinobu, Maeda, Shingo, Komiya, Setsuro, Taniguchi, Noboru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549073/ https://www.ncbi.nlm.nih.gov/pubmed/31059083 http://dx.doi.org/10.3892/or.2019.7150 |
Ejemplares similares
-
Validation of Different Nutritional Assessment Tools in Predicting Prognosis of Patients with Soft Tissue Spindle-Cell Sarcomas
por: Sasaki, Hiromi, et al.
Publicado: (2018) -
TGF-β Promotes the Proliferation of Microglia In Vitro
por: Bureta, Costansia, et al.
Publicado: (2019) -
Smoothened as a new therapeutic target for human osteosarcoma
por: Hirotsu, Masataka, et al.
Publicado: (2010) -
Differentiation of lipoma and atypical lipomatous tumor by a scoring system: implication of increased vascularity on pathogenesis of liposarcoma
por: Nagano, Satoshi, et al.
Publicado: (2015) -
Risk Factors for Surgical Site Infection after Soft-Tissue Sarcoma Resection, Including the Preoperative Geriatric Nutritional Risk Index
por: Sasaki, Hiromi, et al.
Publicado: (2018)